<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Int J Public Health</journal-id><journal-id journal-id-type="publisher-id">Int J Public Health</journal-id><journal-title-group><journal-title>International Journal of Public Health</journal-title></journal-title-group><issn pub-type="ppub">1661-8556</issn><issn pub-type="epub">1661-8564</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40012813</article-id><article-id pub-id-type="pmc">PMC11859585</article-id><article-id pub-id-type="publisher-id">1608133</article-id><article-id pub-id-type="doi">10.3389/ijph.2025.1608133</article-id><article-categories><subj-group subj-group-type="heading"><subject>Public Health Archive</subject><subj-group><subject>Original Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Rural-Urban Disparity in Premature Cancer Mortality in Young People Aged 15&#x02013;44 Years in China, 2004&#x02013;2021</article-title><alt-title alt-title-type="left-running-head">Chen et al.</alt-title><alt-title alt-title-type="right-running-head">Premature Cancer Mortality in China</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Chen</surname><given-names>Chunrong</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/2807915/overview"/></contrib><contrib contrib-type="author"><name><surname>Xing</surname><given-names>Xing</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shaojie</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Qu</surname><given-names>Bo</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Chunyu</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>He</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Radiation Oncology, The First Affiliated Hospital of Qiqihar Medical College</institution>, <addr-line>Qiqihar</addr-line>, <addr-line>Heilongjiang</addr-line>, <country>China</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>School of Public Health</institution>, <institution>Peking University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>China Center for Health Development Studies</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/1002528/overview" ext-link-type="uri">Salvatore Panico</ext-link>, University of Naples Federico II, Italy</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/1609018/overview" ext-link-type="uri">Mario Fordellone</ext-link>, Universit&#x000e0; degli Studi della Campania Luigi Vanvitelli, Italy</p><p>One reviewer who chose to remain anonymous</p></fn><corresp id="c001">*Correspondence: Chunrong Chen, <email>chen.chunrong@qmu.edu.cn</email>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>70</volume><elocation-id>1608133</elocation-id><history><date date-type="received"><day>05</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>31</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Chen, Xing, Li, Qu, Liu and Zhu.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Chen, Xing, Li, Qu, Liu and Zhu</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Objective</title><p>This study aims to examine and compare premature cancer mortality in young people aged 15&#x02013;44&#x000a0;years old between rural and urban areas to inform early-onset cancer prevention.</p></sec><sec><title>Methods</title><p>The data were obtained from the China Death Surveillance Datasets from 2004 to 2021. The study sample consisted of cancer deaths of young people aged 15&#x02013;44&#x000a0;years old. Age-standardized mortality rates (ASMRs) were calculated, and joinpoint regressions were used to examine trends in ASMRs.</p></sec><sec><title>Results</title><p>There were overall decreasing trends in ASMRs for all cancers in both rural and urban young people in China from 2004 to 2021. However, the decrease was relatively slower in rural areas, where ASMRs for pancreatic and ovarian cancers showed increasing trends. The five leading types of cancer deaths consistently remained liver, lung, leukemia, stomach, and other cancers in both rural and urban areas after 2013.</p></sec><sec><title>Conclusion</title><p>Our findings indicate that there were rural-urban disparities in cancer mortality in young people, which showed a different pattern compared to other age groups. More efforts are needed to develop effective early-onset cancer prevention strategies, with particular emphasis on liver cancer and rural areas.</p></sec></abstract><kwd-group><kwd>rural-urban disparity</kwd><kwd>cancer</kwd><kwd>mortality</kwd><kwd>young people</kwd><kwd>age-standardized mortality rate</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was made possible by the Clinical Research of Qiqihar Medical College (grant number: QMSI2021L-06) and the Clinical Research of Health Commission of the Heilongjiang Province (grant number: 20210909030368).</funding-statement></funding-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Concerns regarding early-onset cancers in young people are on the rise both in China and globally. According to estimates from the Global Burden of Disease (GBD), the global incidence number of early-onset cancers reached 3.26 million in 2019 with a 79% increase from 1990, and the number of early-onset cancer deaths rose by approximately 28% between 1990 and 2019 [<xref rid="B1" ref-type="bibr">1</xref>]. Early-onset cancers could potentially lead to premature death, poor quality of life, family financial burden, and healthcare system burden [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>]. The patterns of cancer in young people may differ from those in other age groups and may vary between rural and urban areas [<xref rid="B4" ref-type="bibr">4</xref>]. For example, rural communities experience higher death rates from lung, cervical, and colorectal cancers than urban communities because of poverty, health risk behavior, and lower vaccination and screening rates [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>]. In addition, leukemia and lymphoma are relatively common in adolescents, while lung and colorectal cancers are more prevalent in older populations [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. However, few studies have focused on cancer patterns and rural-urban disparity in young people, particularly in China. Furthermore, young people often fail to recognize the potential seriousness of early symptoms, which can result in delays seeking medical treatment until the cancer has progressed to advanced stages, thereby exacerbating the overall disease burden [<xref rid="B9" ref-type="bibr">9</xref>]. Therefore, there is a clear need to enhance our understanding of the epidemiology of early-onset cancer and mortality in young people.</p><p>In this study, we examined and compared the trends and patterns of premature cancer mortality in young people aged 15&#x02013;44&#x000a0;years old between rural and urban areas in China.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2-1"><title>Data Sources and Study Sample</title><p>The data were obtained from the 2004&#x02013;2021 China Death Surveillance Datasets (CDSDs) [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. The CDSDs are publicly available and are a primary nationally representative source of the mortality data in China. The CDSDs included 161 monitoring sites between 2004 and 2012, covering 31 provinces (autonomous regions and municipalities) and accounting for 6% of the national population. Since 2013, the CDSD has started the data expansion to include 605 monitoring sites, accounting for about 24% of the national population. In order to address underreporting problems and improve the data quality, the data excluded monitoring sites with a &#x02264;3% mortality rate between 2004 and 2012, a &#x02264;5% mortality rate in 2013, and a &#x02264;4.5% after 2013 [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B12" ref-type="bibr">12</xref>]. The data also excluded several sites, which could potentially affect the overall results.</p><p>In this study, we focused on the sample of cancer deaths for young people aged 15&#x02013;44&#x000a0;years old. We identified 17 subtypes of cancer based on the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM): lips/mouth/pharynx (C00-C14), esophagus (C15), stomach (C16), colorectal (C18-C21), liver (C22), pancreatic (C25), lung (C33-C34), skin (C43-C44), breast (C50), cervical (C53), uterine (C54-C55), ovarian (C56), prostate (C61), bladder (C67), lymphoma (C81-C90, C96), leukemia (C91-C95), and other cancers (cancers not specified above in C00-C97, and detailed codes in <xref rid="s11" ref-type="sec">Supplementary Table S1</xref>) [<xref rid="B10" ref-type="bibr">10</xref>].</p></sec><sec id="s2-2"><title>Measures</title><p>Age-standardized mortality rates (ASMRs) for overall and specific types per 100,000 people in the total young population, stratified by urban and rural areas, were calculated from 2004 to 2021. The ASMRs were adjusted based on the World Segi&#x02019;s population structure using the direct calculation method. The rural/urban mortality ratios (R/U ratios) were calculated by dividing the rural cancer ASMRs by the urban cancer ASMRs.</p></sec><sec id="s2-3"><title>Data Analysis</title><p>Descriptive analyses were first used to characterize the distribution of specific cancer types among all cancer deaths stratified by rural and urban areas for 2004, 2012, 2013, and 2021. We selected the years of 2012 and 2013 at midpoints because the dataset expanded its sampling areas in 2013. Next, we calculated ASMRs stratified by cancer type, year, and rural and urban areas, and we also described the trends in ASMRs.</p><p>We conducted joinpoint regressions to estimate the average annual percentage change (AAPC) in ASMRs, which was calculated by averaging the annual percent changes (APCs) derived from the joinpoint regression analysis, with each APC weighted according to the duration of its respective segment within the time interval. Joinpoint regression has been widely used and well-suited for analyzing trends in time series data, particularly in the context of public health data, such as cancer mortality rates [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>]. We also used the change-point analyses to identify thresholds between ASMRs and years to improve the stability of the results and address the sampling expansion issue. All statistical analyses were performed using R software (version 4.3.0; R Foundation for Statistical Computing, Vienna, Austria) and Joinpoint software (version 5.0.2, Applications Branch, National Cancer Institute, United States). A two-tailed p-value &#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3-1"><title>Distribution and Ranking of Cancer Deaths in Young People in Rural and Urban Areas</title><p>Of the sample aged 15&#x02013;44&#x000a0;years old, the distribution of cancer death types remained relatively stable, particularly in urban areas (<xref rid="F1" ref-type="fig">Figure 1</xref>). The five leading cancer types among cancer deaths were liver cancers, lung cancers, other cancers, leukemia, and stomach in both rural and urban areas across years, collectively representing approximately 75% of cases. For example, in 2021, liver cancers (Rank 1st) accounted for 26.41% of cancer deaths in rural areas compared to 20.54% in urban areas; leukemia (Rank 4th) accounted for 9.79% in rural areas and 9.11% in urban areas. Additionally, cancer deaths exhibited a different ranking pattern following the five leading types between rural and urban areas.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Distribution and ranking of cancer deaths in young people aged 15&#x02013;44&#x000a0;years old stratifed by rural and urban areas, China 2004&#x02013;2021. Note: Preliminary ranking results for several low-ranking cancers should be interpreted with caution due to the small sample size.</p></caption><graphic xlink:href="ijph-70-1608133-g001" position="float"/></fig></sec><sec id="s3-2"><title>Rural-Urban Comparison of ASMRs for Cancers in Young People</title><p>In rural areas, the ASMR for all cancers in young people decreased from 25.03 in 2004 to 20.10 in 2012 before the dataset expansion and decreased from 19.06 in 2013 to 14.97 in 2021 after the expansion (<xref rid="T1" ref-type="table">Table 1</xref>). In urban areas, the ASMR for all cancers in young people decreased from 22.44 in 2004 to 13.08 in 2012 before the dataset expansion and decreased from 15.84 in 2013 to 10.77 in 2021 after the expansion.</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>Rural-urban comparison of age-standardized mortality rates (ASMRs) for cancers in young people aged 15&#x02013;44 years old, China 2014&#x02013;2021.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th rowspan="2" align="left" colspan="1">Cancer</th><th colspan="2" align="center" rowspan="1">ASMR 2004</th><th colspan="2" align="center" rowspan="1">ASMR 2012</th><th colspan="2" align="center" rowspan="1">ASMR 2013</th><th colspan="2" align="center" rowspan="1">ASMR 2021</th><th rowspan="2" align="center" colspan="1">R/U ratio 2004</th><th rowspan="2" align="center" colspan="1">R/U ratio 2012</th><th rowspan="2" align="center" colspan="1">R/U ratio 2013</th><th rowspan="2" align="center" colspan="1">R/U ratio 2021</th></tr><tr><th align="center" rowspan="1" colspan="1">Rural</th><th align="center" rowspan="1" colspan="1">Urban</th><th align="center" rowspan="1" colspan="1">Rural</th><th align="center" rowspan="1" colspan="1">Urban</th><th align="center" rowspan="1" colspan="1">Rural</th><th align="center" rowspan="1" colspan="1">Urban</th><th align="center" rowspan="1" colspan="1">Rural</th><th align="center" rowspan="1" colspan="1">Urban</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">25.03</td><td align="center" rowspan="1" colspan="1">22.44</td><td align="center" rowspan="1" colspan="1">20.10</td><td align="center" rowspan="1" colspan="1">13.08</td><td align="center" rowspan="1" colspan="1">19.06</td><td align="center" rowspan="1" colspan="1">15.84</td><td align="center" rowspan="1" colspan="1">14.97</td><td align="center" rowspan="1" colspan="1">10.77</td><td align="center" rowspan="1" colspan="1">1.12</td><td align="center" rowspan="1" colspan="1">1.54</td><td align="center" rowspan="1" colspan="1">1.20</td><td align="center" rowspan="1" colspan="1">1.39</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver</td><td align="center" rowspan="1" colspan="1">7.63</td><td align="center" rowspan="1" colspan="1">5.26</td><td align="center" rowspan="1" colspan="1">5.69</td><td align="center" rowspan="1" colspan="1">2.89</td><td align="center" rowspan="1" colspan="1">4.84</td><td align="center" rowspan="1" colspan="1">3.59</td><td align="center" rowspan="1" colspan="1">3.80</td><td align="center" rowspan="1" colspan="1">2.09</td><td align="center" rowspan="1" colspan="1">1.45</td><td align="center" rowspan="1" colspan="1">1.97</td><td align="center" rowspan="1" colspan="1">1.35</td><td align="center" rowspan="1" colspan="1">1.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Others</td><td align="center" rowspan="1" colspan="1">2.86</td><td align="center" rowspan="1" colspan="1">3.30</td><td align="center" rowspan="1" colspan="1">3.00</td><td align="center" rowspan="1" colspan="1">1.88</td><td align="center" rowspan="1" colspan="1">3.50</td><td align="center" rowspan="1" colspan="1">2.49</td><td align="center" rowspan="1" colspan="1">2.59</td><td align="center" rowspan="1" colspan="1">1.96</td><td align="center" rowspan="1" colspan="1">0.94</td><td align="center" rowspan="1" colspan="1">1.59</td><td align="center" rowspan="1" colspan="1">1.40</td><td align="center" rowspan="1" colspan="1">1.32</td></tr><tr><td align="left" rowspan="1" colspan="1">Lung</td><td align="center" rowspan="1" colspan="1">2.92</td><td align="center" rowspan="1" colspan="1">3.59</td><td align="center" rowspan="1" colspan="1">2.74</td><td align="center" rowspan="1" colspan="1">1.76</td><td align="center" rowspan="1" colspan="1">2.41</td><td align="center" rowspan="1" colspan="1">2.19</td><td align="center" rowspan="1" colspan="1">1.72</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">1.56</td><td align="center" rowspan="1" colspan="1">1.10</td><td align="center" rowspan="1" colspan="1">1.48</td></tr><tr><td align="left" rowspan="1" colspan="1">Leukemia</td><td align="center" rowspan="1" colspan="1">2.97</td><td align="center" rowspan="1" colspan="1">2.56</td><td align="center" rowspan="1" colspan="1">2.28</td><td align="center" rowspan="1" colspan="1">1.45</td><td align="center" rowspan="1" colspan="1">2.21</td><td align="center" rowspan="1" colspan="1">1.67</td><td align="center" rowspan="1" colspan="1">1.64</td><td align="center" rowspan="1" colspan="1">1.15</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">1.57</td><td align="center" rowspan="1" colspan="1">1.32</td><td align="center" rowspan="1" colspan="1">1.43</td></tr><tr><td align="left" rowspan="1" colspan="1">Stomach</td><td align="center" rowspan="1" colspan="1">2.48</td><td align="center" rowspan="1" colspan="1">2.42</td><td align="center" rowspan="1" colspan="1">1.68</td><td align="center" rowspan="1" colspan="1">1.10</td><td align="center" rowspan="1" colspan="1">1.41</td><td align="center" rowspan="1" colspan="1">1.23</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">1.02</td><td align="center" rowspan="1" colspan="1">1.52</td><td align="center" rowspan="1" colspan="1">1.14</td><td align="center" rowspan="1" colspan="1">1.10</td></tr><tr><td align="left" rowspan="1" colspan="1">Colorectal</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">1.12</td><td align="center" rowspan="1" colspan="1">0.98</td><td align="center" rowspan="1" colspan="1">0.79</td><td align="center" rowspan="1" colspan="1">0.88</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">1.04</td><td align="center" rowspan="1" colspan="1">1.25</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="center" rowspan="1" colspan="1">1.33</td></tr><tr><td align="left" rowspan="1" colspan="1">Breast</td><td align="center" rowspan="1" colspan="1">1.03</td><td align="center" rowspan="1" colspan="1">1.24</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.76</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.92</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.84</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">1.19</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">1.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphoma</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.52</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">0.61</td><td align="center" rowspan="1" colspan="1">0.73</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.50</td><td align="center" rowspan="1" colspan="1">0.47</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">1.03</td><td align="center" rowspan="1" colspan="1">1.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Lips/mouth/pharynx</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">0.50</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">0.32</td><td align="center" rowspan="1" colspan="1">1.22</td><td align="center" rowspan="1" colspan="1">1.33</td><td align="center" rowspan="1" colspan="1">1.01</td><td align="center" rowspan="1" colspan="1">1.50</td></tr><tr><td align="left" rowspan="1" colspan="1">Cervical</td><td align="center" rowspan="1" colspan="1">0.56</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.39</td><td align="center" rowspan="1" colspan="1">0.39</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">0.45</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">1.04</td><td align="center" rowspan="1" colspan="1">1.17</td><td align="center" rowspan="1" colspan="1">0.74</td><td align="center" rowspan="1" colspan="1">1.27</td></tr><tr><td align="left" rowspan="1" colspan="1">Pancreas</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">0.34</td><td align="center" rowspan="1" colspan="1">0.27</td><td align="center" rowspan="1" colspan="1">0.28</td><td align="center" rowspan="1" colspan="1">0.28</td><td align="center" rowspan="1" colspan="1">0.28</td><td align="center" rowspan="1" colspan="1">0.30</td><td align="center" rowspan="1" colspan="1">0.32</td><td align="center" rowspan="1" colspan="1">0.77</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">0.96</td></tr><tr><td align="left" rowspan="1" colspan="1">Ovarian</td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">0.32</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">0.26</td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.19</td><td align="center" rowspan="1" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">0.53</td><td align="center" rowspan="1" colspan="1">0.58</td><td align="center" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" rowspan="1" colspan="1">Esophagus</td><td align="center" rowspan="1" colspan="1">1.06</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.35</td><td align="center" rowspan="1" colspan="1">0.19</td><td align="center" rowspan="1" colspan="1">0.30</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">0.17</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">2.29</td><td align="center" rowspan="1" colspan="1">1.81</td><td align="center" rowspan="1" colspan="1">1.43</td><td align="center" rowspan="1" colspan="1">1.83</td></tr><tr><td align="left" rowspan="1" colspan="1">Uterine</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">0.39</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.41</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">0.15</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">1.88</td><td align="center" rowspan="1" colspan="1">2.49</td><td align="center" rowspan="1" colspan="1">1.40</td><td align="center" rowspan="1" colspan="1">1.34</td></tr><tr><td align="left" rowspan="1" colspan="1">Skin</td><td align="center" rowspan="1" colspan="1">0.14</td><td align="center" rowspan="1" colspan="1">0.06</td><td align="center" rowspan="1" colspan="1">0.06</td><td align="center" rowspan="1" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">0.10</td><td align="center" rowspan="1" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">2.50</td><td align="center" rowspan="1" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">1.30</td><td align="center" rowspan="1" colspan="1">1.70</td></tr><tr><td align="left" rowspan="1" colspan="1">Bladder</td><td align="center" rowspan="1" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">0.10</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">0.06</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">2.11</td><td align="center" rowspan="1" colspan="1">2.45</td></tr><tr><td align="left" rowspan="1" colspan="1">Prostate</td><td align="center" rowspan="1" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">0.00<xref rid="Tfn1" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">0.00<xref rid="Tfn1" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">0.01</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.00<xref rid="Tfn1" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" rowspan="1" colspan="1">1.18</td><td align="center" rowspan="1" colspan="1">1.47</td></tr></tbody></table><table-wrap-foot><fn id="Tfn1"><label>
<sup>a</sup>
</label><p>Being 0.00 due to keeping two decimals.</p></fn></table-wrap-foot></table-wrap><p>Although both rural and urban ASMRs generally showed decreasing trends, the R/U ratio increased, measuring 1.12 in 2004, 1.54 in 2012, 1.20 in 2013, and 1.39 in 2021. In 2021, the R/U ratios for esophagus cancer (1.83), liver cancer (1.82), skin cancer (1.70), and lips/mouth/pharynx cancer (1.50) were relatively high. In contrast, the R/U ratios for pancreas (0.96) and ovarian cancers (0.95) were both below 1. Additionally, the R/U ratios for lymphoma and bladder cancers increased to be more than 1 following the dataset expansion.</p></sec><sec id="s3-3"><title>Trends in ASMRs for Cancers in Young People Stratified by Rural and Urban Areas</title><p>Overall, the ASMR for all cancers in young people decreased by 46.41% (AAPC = &#x02212;2.74, 95% CI: &#x02212;3.21, 2.26) in rural areas and 70.21% (AAPC = &#x02212;4.13, 95% CI: &#x02212;4.90, 3.34) in urban areas between 2004 and 2021 (<xref rid="F2" ref-type="fig">Figure 2</xref>). The ASMRs for liver, lung, leukemia, and stomach cancers decreased by approximately 50%&#x02013;90% in both areas; however, the ASMRs for other cancers did not change significantly during this period in rural areas. Although the ASMRs for most cancers decreased, the ASMRs for pancreatic and ovarian cancers in rural areas increased by 27.54% (AAPC = 1.62, 95% CI: 0.17, 3.14) and 37.91% (AAPC = 2.23, 95% CI: 1.13, 3.34), respectively, from 2004&#x02013;2021.</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Trends in age-standardized mortality rates (ASMRs) for cancers in young people aged 15&#x02013;44 years old stratified by rural and urban areas, China 2004&#x02013;2021. *The average annual percentage change (AAPC) is significantly different from zero (<italic>P</italic> &#x0003c; 0.05).</p></caption><graphic xlink:href="ijph-70-1608133-g002" position="float"/></fig><p>In addition, both joinpoint and changepoint regressions detected no significant changes in ASMRs for all cancers; however, they identified changes in ASMR for liver cancer in urban areas in 2010 and 2013, for lung cancers in rural areas in 2014, and for other cancers in rural areas in 2013 (<xref rid="s11" ref-type="sec">Supplementary Tables S2, S3</xref>).</p></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>This study is among the first to examine premature cancer mortality in young people in China. The results indicate that liver, lung, leukemia, stomach, and other cancers consistently contributed to premature cancer mortality in both rural and urban young people in China from 2004 to 2021. Although the ASMRs for all cancers in young people showed decreasing trends, ASMRs for most cancers were higher in rural areas compared to urban areas, particularly for liver cancers. Furthermore, ASMRs for pancreatic and ovarian cancers in rural areas exhibited upward trends. These findings have important implications for informing the development of early-onset cancer prevention strategies.</p><p>Our findings indicated that there were decreasing trends in ASMRs for cancers in both rural and urban young people, but the decrease was relatively slower in rural areas. Similarly, a global study found that the morbidity rates of early-onset cancer increased from 1990 to 2019, while mortality rates and disability-adjusted life years (DALYs) slightly decreased [<xref rid="B1" ref-type="bibr">1</xref>]. Recent studies in Europe also exhibited potential differences in the prevalence of early-onset cancers between metropolitan and rural areas, with the geographical distribution identified as a risk factor [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>]. This decrease in China may be attributed to government prevention efforts and advancements in cancer treatment. Both central and local governments have intensified their initiatives to implement cancer prevention and control actions of the Healthy China 2030 including expanding screening, improving early diagnosis and treatment, and developing standardized treatments [<xref rid="B17" ref-type="bibr">17</xref>]. Research indicates rural areas generally have lower health literacy compared to urban areas, which may contribute to higher mortality rates, primarily due to factors such as lower educational levels, socioeconomic disadvantages, and physical labor engagement. For example, a study reported that urban residents had higher rates of health-promoting behaviors and lifestyle habits (urban vs. rural: 14.03% vs. 7.33%), as well as higher rates of health knowledge and concept awareness (urban vs. rural: 34.50% vs. 20.42%) than rural counterparts in China [<xref rid="B18" ref-type="bibr">18</xref>]. The disparity between urban and rural areas may also be linked to elevated cancer incidence rates and prolonged periods before cancer diagnosis in rural areas [<xref rid="B19" ref-type="bibr">19</xref>]. With the anticipated rise in early-onset cancers, we recommend the implementation of more effective health interventions to improve public awareness regarding cancer prevention and routine screening, particularly among rural young people.</p><p>Our findings also identified potential trend changes in ASMRs, which disproportionally affect liver, lung, and other cancers in urban and rural areas in 2010, 2013, and 2014. The potential changepoint identified in 2010 for liver cancer deaths in urban areas may be related to the implementation of China&#x02019;s basic public health policy in 2009 and free HBV vaccine programs [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. In 1992, the former Ministry of Health included HBV vaccines in the children&#x02019;s immunization program, and the national HBV vaccination rate reached 70.7% in 1999 [<xref rid="B21" ref-type="bibr">21</xref>]. These changes could have contributed to early improvements in health outcomes, influencing the cancer mortality trends. The changes in 2013 and 2014 for urban liver cancer deaths and rural lung and other cancer deaths may be influenced by the CDSD expansion in China [<xref rid="B11" ref-type="bibr">11</xref>]. As mentioned in the methods, the CDSD monitoring sites reached to be 605 in 2013 compared to 161 in 2012 or earlier. Either 161 or 605 design is a nationally represent samples in China; however, due to limited experiences in collecting and managing the data, the new data may be affected. A study from China CDC as the data management agency examined the trends in chronic diseases in older people from 2004 to 2018, and it discussed that the data expansion in 2013 may suffer the underreporting issues to underestimate the mortality rate [<xref rid="B12" ref-type="bibr">12</xref>]. More studies are needed to monitor the trends and changes in early-onset cancer incidence and mortality rates.</p><p>Our findings revealed that the top five cancers leading to deaths in young people in China were liver, lung, stomach, leukemia, and other cancers, with stable ranking in both urban and rural areas, which showed a different pattern compared to other age groups. According to an estimate based on 700 registries reporting high-quality data on cancer incidence and mortality across China, the top five cancers leading to deaths were lung, liver, colon-rectum, esophagus, and other cancers in 2022 [<xref rid="B22" ref-type="bibr">22</xref>]. Notably, liver cancer and leukemia in young people were more likely to result in cancer deaths compared to in the general population or older population, especially in rural areas [<xref rid="B23" ref-type="bibr">23</xref>]. Infection with the hepatitis B virus (HBV), excessive alcohol consumption, and exposure to aflatoxin are recognized as significant risk factors for liver cancer [<xref rid="B24" ref-type="bibr">24</xref>]. HBV infection remains the predominant risk factor for liver cancer in China, accounting for 63%&#x02013;67% of all liver cancer cases [<xref rid="B25" ref-type="bibr">25</xref>]. Although the prevalence of HBV has decreased due to the national immunization program, the HBV infection rate is higher in rural areas than in urban areas, which may contribute to increased cancer mortality for young people in rural areas [<xref rid="B26" ref-type="bibr">26</xref>]. Rural areas continue to carry the heavy burden of chronic HBV infection, and mortality from HBV-related liver cancer is expected to remain at high levels in the coming decades [<xref rid="B26" ref-type="bibr">26</xref>]. Therefore, more efforts are needed to enhance early prevention and detection for rural young people with HBV.</p><p>In addition, leukemia is one of the leading causes of cancer deaths among children and adolescents in China, and rural people generally experience higher mortality rates and disease burdens compared urban people, which aligns with our findings [<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>]. Numerous studies have demonstrated associations between leukemia incidence and environmental exposure. Particularly among rural males employed in factories, significant exposures to ionizing radiation and benzene solvents during industrial production are closely linked with increased leukemia mortality rates [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>]. Prior studies have observed excess leukemia risks among individuals, engaged in agriculture or livestock farming who were exposed to pesticides and infectious pathogens [<xref rid="B31" ref-type="bibr">31</xref>]. Therefore, health education and necessary occupation protection should be implemented to reduce exposure to carcinogenic substances among high-risk populations at an early stage.</p><p>Our findings also indicate that pancreatic and ovarian cancer deaths have increased from 2004 to 2021 in rural young adults. Both pancreatic cancer and ovarian cancers are highly lethal malignancy, with delayed diagnosis being the primary reason for their high mortality rates. According to a clinical study conducted in China, fewer than 20% of pancreatic cancer patients are diagnosed in the early stages of their disease [<xref rid="B32" ref-type="bibr">32</xref>]. Early-stage pancreatic and ovarian cancers often present few obvious symptoms and typically become apparent only when the cancer has invaded surrounding tissues or organs at advanced stages [<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>]. Approximately 70% of ovarian cancer patients were diagnosed at advanced stages, and there is currently a lack of effective early diagnostic techniques [<xref rid="B35" ref-type="bibr">35</xref>]. Alcohol abuse, smoking, and a high intake of processed meat have been shown to be associated with the development of pancreatic cancer [<xref rid="B33" ref-type="bibr">33</xref>]. Insufficient dietary fiber and vitamin intake, diabetes, and obesity are potential risk factors for ovarian cancers [<xref rid="B34" ref-type="bibr">34</xref>]. Promoting access to the routine screening and healthy lifestyles are essential for reducing the cancer risk and improving health outcomes, particularly for rural young people.</p><p>These findings should be interpreted with caution. First, the sampling expansion of the CDSD in 2013 may affect the continuity and comparability of data across years. Although the data collection agency implemented quality control procedures of excluding monitoring sites with low-quality data, there remains a possibility of the underreporting and underestimating cancer deaths. Several studies have examined the trends in deaths including periods before and after 2013; however, few of these studies, as well as no official reports, discussed the potential influences of the data expansion on the results. Second, the cancer death data in this study are cumulative data due to the availability of data from the CDSDs, and there is no individual-level information on socioeconomic, environmental, or behavioral factors that may contribute to or explain disparities. Future studies are needed to investigate the specific differences in cancer deaths between rural and urban young people. Third, despite multiple verification procedures to improve data accuracy, the diagnosing bias in cancer deaths may exist and vary across hospitals. Finally, the data did not allow for the specification of cases classified into other cancers, which may limit the interpretability of the results.</p></sec></body><back><sec sec-type="data-availability" id="s5"><title>Data Availability Statement</title><p>The original data for this study can be accessed at: <ext-link xlink:href="https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/" ext-link-type="uri">https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/</ext-link>. The data used in this study was accessed on 10 March 2024.</p></sec><sec sec-type="author-contributions" id="s6"><title>Author Contributions</title><p>CC designed the study and drafted the manuscript; XX conducted the data analyses under the supervision of HZ; SL prepared the data and revised the manuscript; BQ and CL conducted the literature review and revised the manuscript; HZ designed the study, guided the data analyses, and revised the manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="disclaimer" id="s8"><title>Author Disclaimer</title><p>The opinions expressed in this paper are solely those of the authors.</p></sec><sec sec-type="COI-statement" id="s9"><title>Conflict of Interest</title><p>The authors declare that they do not have any conflicts of interest.</p></sec><sec sec-type="ai-statement" id="s10"><title>Generative AI Statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec id="s11"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.ssph-journal.org/articles/10.3389/ijph.2025.1608133/full#supplementary-material" ext-link-type="uri">https://www.ssph-journal.org/articles/10.3389/ijph.2025.1608133/full#supplementary-material</ext-link>
</p><supplementary-material id="SM1" position="float" content-type="local-data"><media xlink:href="DataSheet1.doc"/></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Global Trends in Incidence, Death, Burden and Risk Factors of Early-Onset Cancer From 1990 to 2019</article-title>. <source>BMJ Oncol</source> (<year>2023</year>) <volume>2</volume>:<fpage>e000049</fpage>. <pub-id pub-id-type="doi">10.1136/bmjonc-2023-000049</pub-id>
</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Akinyemiju</surname><given-names>T</given-names></name></person-group>. <article-title>Early-Onset Cancer Incidence in the United States by Race/Ethnicity Between 2011 and 2020</article-title>. <source>Cancer Epidemiol</source> (<year>2024</year>) <volume>92</volume>:<fpage>102632</fpage>. <pub-id pub-id-type="doi">10.1016/j.canep.2024.102632</pub-id>
<pub-id pub-id-type="pmid">39094298</pub-id>
</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ugai</surname><given-names>T</given-names></name><name><surname>Sasamoto</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Ando</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Tamimi</surname><given-names>RM</given-names></name><etal/></person-group>
<article-title>Is Early-Onset Cancer an Emerging Global Epidemic? Current Evidence and Future Implications</article-title>. <source>Nat Rev Clin Oncol</source> (<year>2022</year>) <volume>19</volume>(<issue>10</issue>):<fpage>656</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/s41571-022-00672-8</pub-id>
<pub-id pub-id-type="pmid">36068272</pub-id>
</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mauri</surname><given-names>G</given-names></name><name><surname>Patelli</surname><given-names>G</given-names></name><name><surname>Sartore-Bianchi</surname><given-names>A</given-names></name><name><surname>Abrignani</surname><given-names>S</given-names></name><name><surname>Bodega</surname><given-names>B</given-names></name><name><surname>Marsoni</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Early-Onset Cancers: Biological Bases and Clinical Implications</article-title>. <source>Cell Rep Med</source> (<year>2024</year>) <volume>5</volume>(<issue>9</issue>):<fpage>101737</fpage>. <pub-id pub-id-type="doi">10.1016/j.xcrm.2024.101737</pub-id>
<pub-id pub-id-type="pmid">39260369</pub-id>
</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Minas</surname><given-names>TZ</given-names></name><name><surname>Kiely</surname><given-names>M</given-names></name><name><surname>Ajao</surname><given-names>A</given-names></name><name><surname>Ambs</surname><given-names>S</given-names></name></person-group>. <article-title>An Overview of Cancer Health Disparities: New Approaches and Insights and Why They Matter</article-title>. <source>Carcinogenesis</source> (<year>2021</year>) <volume>42</volume>(<issue>1</issue>):<fpage>2</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgaa121</pub-id>
<pub-id pub-id-type="pmid">33185680</pub-id>
</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henley</surname><given-names>SJ</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group>. <article-title>Rural Cancer Control: Bridging the Chasm in Geographic Health Inequity</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> (<year>2018</year>) <volume>27</volume>(<issue>11</issue>):<fpage>1248</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-18-0807</pub-id>
<pub-id pub-id-type="pmid">30385497</pub-id>
</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fidler</surname><given-names>MM</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Steliarova-Foucher</surname><given-names>E</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name></person-group>. <article-title>Cancer Incidence and Mortality Among Young Adults Aged 20&#x02013;39 Years Worldwide in 2012: A Population-Based Study</article-title>. <source>Lancet Oncol</source> (<year>2017</year>) <volume>18</volume>(<issue>12</issue>):<fpage>1579</fpage>&#x02013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(17)30677-0</pub-id>
<pub-id pub-id-type="pmid">29111259</pub-id>
</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barr</surname><given-names>RD</given-names></name><name><surname>Holowaty</surname><given-names>EJ</given-names></name><name><surname>Birch</surname><given-names>JM</given-names></name></person-group>. <article-title>Classification Schemes for Tumors Diagnosed in Adolescents and Young Adults</article-title>. <source>Cancer</source> (<year>2006</year>) <volume>106</volume>(<issue>7</issue>):<fpage>1425</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.21773</pub-id>
<pub-id pub-id-type="pmid">16544312</pub-id>
</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>AW</given-names></name><name><surname>Ramirez</surname><given-names>AJ</given-names></name><name><surname>Hamilton</surname><given-names>W</given-names></name><name><surname>Sasieni</surname><given-names>P</given-names></name><name><surname>Patnick</surname><given-names>J</given-names></name><name><surname>Forbes</surname><given-names>LJ</given-names></name></person-group>. <article-title>Delays in Diagnosis of Young Females With Symptomatic Cervical Cancer in England: An Interview-Based Study</article-title>. <source>Br J Gen Pract</source> (<year>2014</year>) <volume>64</volume>(<issue>627</issue>):<fpage>e602</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.3399/bjgp14X681757</pub-id>
<pub-id pub-id-type="pmid">25267045</pub-id>
</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="book">
<collab>Chinacdc</collab>. <source>China Death Surveillance Datasets (CDSDs)</source> (<year>2025</year>). <comment>Available from: <ext-link xlink:href="https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/" ext-link-type="uri">https://ncncd.chinacdc.cn/jcysj/siyinjcx/syfxbg/</ext-link> (Accessed June 10, 2024).</comment>
</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Page</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>An Integrated National Mortality Surveillance System for Death Registration and Mortality Surveillance, China</article-title>. <source>Bull World Health Organ</source> (<year>2016</year>) <volume>94</volume>(<issue>1</issue>):<fpage>46</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.2471/BLT.15.153148</pub-id>
<pub-id pub-id-type="pmid">26769996</pub-id>
</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xia</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>W</given-names></name><name><surname>Mao</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name></person-group>. <article-title>Chronic and Non-Communicable Disease Mortality and Trends in Chinese Elderly, 2004-2018</article-title>. <source>Chin J Epidemiol</source> (<year>2021</year>) <volume>42</volume>(<issue>3</issue>):<fpage>499</fpage>&#x02013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn112338-20200208-00079</pub-id>
</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hung</surname><given-names>BT</given-names></name><name><surname>Long</surname><given-names>NP</given-names></name><name><surname>Hung</surname><given-names>le P</given-names></name><name><surname>Luan</surname><given-names>NT</given-names></name><name><surname>Anh</surname><given-names>NH</given-names></name><name><surname>Nghi</surname><given-names>TD</given-names></name><etal/></person-group>
<article-title>Research Trends in Evidence-Based Medicine: A Joinpoint Regression Analysis of More Than 50 Years of Publication Data</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>(<issue>4</issue>):<fpage>e0121054</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0121054</pub-id>
<pub-id pub-id-type="pmid">25849641</pub-id>
</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Fay</surname><given-names>MP</given-names></name><name><surname>Feuer</surname><given-names>EJ</given-names></name><name><surname>Midthune</surname><given-names>DN</given-names></name></person-group>. <article-title>Permutation Tests for Joinpoint Regression With Applications to Cancer Rates</article-title>. <source>Stat Med</source> (<year>2000</year>) <volume>19</volume>(<issue>3</issue>):<fpage>335</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1097-0258(20000215)19:3&#x0003c;335::aid-sim336&#x0003e;3.0.co;2-z</pub-id>
<pub-id pub-id-type="pmid">10649300</pub-id>
</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vuik</surname><given-names>FE</given-names></name><name><surname>Nieuwenburg</surname><given-names>SA</given-names></name><name><surname>Bardou</surname><given-names>M</given-names></name><name><surname>Lansdorp-Vogelaar</surname><given-names>I</given-names></name><name><surname>Dinis-Ribeiro</surname><given-names>M</given-names></name><name><surname>Bento</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>Increasing Incidence of Colorectal Cancer in Young Adults in Europe Over the Last 25 Years</article-title>. <source>Gut</source> (<year>2019</year>) <volume>68</volume>(<issue>10</issue>):<fpage>1820</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2018-317592</pub-id>
<pub-id pub-id-type="pmid">31097539</pub-id>
</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Russo</surname><given-names>AG</given-names></name><name><surname>Andreano</surname><given-names>A</given-names></name><name><surname>Sartore-Bianchi</surname><given-names>A</given-names></name><name><surname>Mauri</surname><given-names>G</given-names></name><name><surname>Decarli</surname><given-names>A</given-names></name><name><surname>Siena</surname><given-names>S</given-names></name></person-group>. <article-title>Increased Incidence of Colon Cancer Among Individuals Younger Than 50 Years: A 17 Years Analysis from the Cancer Registry of the Municipality of Milan, Italy</article-title>. <source>Cancer Epidemiol</source> (<year>2019</year>) <volume>60</volume>:<fpage>134</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.canep.2019.03.015</pub-id>
<pub-id pub-id-type="pmid">31005829</pub-id>
</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="book">
<collab>Zhengce</collab>. <source>Healthy China Action &#x02014; Implementation Plan for Cancer Prevention and Control (2023-2030)</source>. <publisher-name>Chinese</publisher-name> (<year>2025</year>). <comment>Available from: <ext-link xlink:href="https://www.gov.cn/zhengce/202311/content_6915389.htm?ddtab=true" ext-link-type="uri">https://www.gov.cn/zhengce/202311/content_6915389.htm?ddtab=true</ext-link> (Accessed June 10, 2024).</comment>
</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Mei</surname><given-names>Y</given-names></name><name><surname>Ping</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group>. <article-title>The Urban-Rural Disparity in the Status and Risk Factors of Health Literacy: A Cross-Sectional Survey in Central China</article-title>. <source>Int J Environ Res Public Health</source> (<year>2020</year>) <volume>17</volume>(<issue>11</issue>):<fpage>3848</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17113848</pub-id>
<pub-id pub-id-type="pmid">32485790</pub-id>
</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petersen</surname><given-names>GS</given-names></name><name><surname>Laursen</surname><given-names>SGW</given-names></name><name><surname>Jensen</surname><given-names>H</given-names></name><name><surname>Maindal</surname><given-names>HT</given-names></name><name><surname>Pedersen</surname><given-names>AF</given-names></name><name><surname>Vedsted</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Patients&#x02019; Health Literacy Is Associated With Timely Diagnosis of Cancer-A Cross-Sectional Study in Denmark</article-title>. <source>Eur J Cancer Care (Engl)</source> (<year>2022</year>) <volume>31</volume>(<issue>1</issue>):<fpage>e13532</fpage>. <pub-id pub-id-type="doi">10.1111/ecc.13532</pub-id>
<pub-id pub-id-type="pmid">34704640</pub-id>
</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wagstaff</surname><given-names>A</given-names></name><name><surname>Yip</surname><given-names>W</given-names></name><name><surname>Lindelow</surname><given-names>M</given-names></name><name><surname>Hsiao</surname><given-names>WC</given-names></name></person-group>. <article-title>China&#x02019;s Health System and its Reform: A Review of Recent Studies</article-title>. <source>Health Econ</source> (<year>2009</year>) <volume>18</volume>(<issue>Suppl. 2</issue>):<fpage>S7</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1002/hec.1518</pub-id>
<pub-id pub-id-type="pmid">19551753</pub-id>
</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="book">
<source>China Has Achieved Significant Results in Controlling Hepatitis B</source> (<year>2013</year>) <comment>Available from: <ext-link xlink:href="http://www.nhc.gov.cn/jkj/s3582/201307/518216575e544109b2caca07fca3b430.shtml" ext-link-type="uri">http://www.nhc.gov.cn/jkj/s3582/201307/518216575e544109b2caca07fca3b430.shtml</ext-link> (Accessed October 1, 2024).</comment>
</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Cancer Incidence and Mortality in China, 2022</article-title>. <source>J Natl Cancer Cent</source> (<year>2024</year>) <volume>4</volume>(<issue>1</issue>):<fpage>47</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.jncc.2024.01.006</pub-id>
<pub-id pub-id-type="pmid">39036382</pub-id>
</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name></person-group>. <article-title>Liver Cancer in China: The Analysis of Mortality and Burden of Disease Trends from 2008 to 2021</article-title>. <source>BMC Cancer</source> (<year>2024</year>) <volume>24</volume>(<issue>1</issue>):<fpage>594</fpage>. <pub-id pub-id-type="doi">10.1186/s12885-024-12334-2</pub-id>
<pub-id pub-id-type="pmid">38750424</pub-id>
</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>JG</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>Lu</surname><given-names>JH</given-names></name><name><surname>Kensler</surname><given-names>TW</given-names></name></person-group>. <article-title>Liver Cancer Etiology: Old Issues and New Perspectives</article-title>. <source>Curr Oncol Rep</source> (<year>2024</year>) <volume>26</volume>(<issue>11</issue>):<fpage>1452</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1007/s11912-024-01605-7</pub-id>
<pub-id pub-id-type="pmid">39388026</pub-id>
</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>SL</given-names></name><name><surname>Cao</surname><given-names>MM</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>XX</given-names></name><name><surname>He</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>Analysis of Changing Trends in Disease Burden of Liver Cancer Among Chinese Population from 1990 to 2019</article-title>. <source>Chin J Dig Surg</source> (<year>2023</year>) <volume>22</volume>(<issue>1</issue>):<fpage>122</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.cn115610-20221112-00687</pub-id>
</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Suo</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Changing Prevalence of Chronic Hepatitis B Virus Infection in China between 1973 and 2021: A Systematic Literature Review and Meta-Analysis of 3740 Studies and 231 Million People</article-title>. <source>Gut</source> (<year>2023</year>) <volume>72</volume>(<issue>12</issue>):<fpage>2354</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2023-330691</pub-id>
<pub-id pub-id-type="pmid">37798085</pub-id>
</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>K</given-names></name><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Epidemiological Characteristics of Leukemia in China, 2005-2017: A Log-Linear Regression and Age-Period-Cohort Analysis</article-title>. <source>BMC Public Health</source> (<year>2023</year>) <volume>23</volume>(<issue>1</issue>):<fpage>1647</fpage>. <pub-id pub-id-type="doi">10.1186/s12889-023-16226-1</pub-id>
<pub-id pub-id-type="pmid">37641011</pub-id>
</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>H</given-names></name></person-group>. <article-title>The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China</article-title>. <source>Front Public Health</source> (<year>2020</year>) <volume>8</volume>:<fpage>598215</fpage>. <pub-id pub-id-type="doi">10.3389/fpubh.2020.598215</pub-id>
<pub-id pub-id-type="pmid">33363091</pub-id>
</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richardson</surname><given-names>DB</given-names></name><name><surname>Wing</surname><given-names>S</given-names></name></person-group>. <article-title>Leukemia Mortality Among Workers at the Savannah River Site</article-title>. <source>Am J Epidemiol</source> (<year>2007</year>) <volume>166</volume>(<issue>9</issue>):<fpage>1015</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwm176</pub-id>
<pub-id pub-id-type="pmid">17660455</pub-id>
</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khalade</surname><given-names>A</given-names></name><name><surname>Jaakkola</surname><given-names>MS</given-names></name><name><surname>Pukkala</surname><given-names>E</given-names></name><name><surname>Jaakkola</surname><given-names>JJ</given-names></name></person-group>. <article-title>Exposure to Benzene at Work and the Risk of Leukemia: A Systematic Review and Meta-Analysis</article-title>. <source>Environ Health</source> (<year>2010</year>) <volume>9</volume>:<fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/1476-069X-9-31</pub-id>
<pub-id pub-id-type="pmid">20584305</pub-id>
</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rusiecki</surname><given-names>JA</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Koutros</surname><given-names>S</given-names></name><name><surname>Beane-Freeman</surname><given-names>L</given-names></name><name><surname>Landgren</surname><given-names>O</given-names></name><name><surname>Bonner</surname><given-names>MR</given-names></name><etal/></person-group>
<article-title>Cancer Incidence Among Pesticide Applicators Exposed to Permethrin in the Agricultural Health Study</article-title>. <source>Environ Health Perspect</source> (<year>2009</year>) <volume>117</volume>(<issue>4</issue>):<fpage>581</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.11318</pub-id>
<pub-id pub-id-type="pmid">19440497</pub-id>
</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>QH</given-names></name><name><surname>Ni</surname><given-names>QX</given-names></name></person-group>, <collab>Coordination Group of The Committee on Pancreatic Cancer</collab>. <article-title>Clinical Analysis of 2340 Cases of Pancreatic Cancer</article-title>. <source>Zhonghua Yi Xue Za Zhi</source> (<year>2004</year>) <volume>84</volume>(<issue>3</issue>):<fpage>214</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3760/j:issn:0376-2491.2004.03.010</pub-id>
<pub-id pub-id-type="pmid">15059537</pub-id>
</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vincent</surname><given-names>A</given-names></name><name><surname>Herman</surname><given-names>J</given-names></name><name><surname>Schulick</surname><given-names>R</given-names></name><name><surname>Hruban</surname><given-names>RH</given-names></name><name><surname>Goggins</surname><given-names>M</given-names></name></person-group>. <article-title>Pancreatic Cancer</article-title>. <source>Lancet</source> (<year>2011</year>) <volume>378</volume>(<issue>9791</issue>):<fpage>607</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)62307-0</pub-id>
<pub-id pub-id-type="pmid">21620466</pub-id>
</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matulonis</surname><given-names>UA</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name><name><surname>Fallowfield</surname><given-names>L</given-names></name><name><surname>Howitt</surname><given-names>BE</given-names></name><name><surname>Sehouli</surname><given-names>J</given-names></name><name><surname>Karlan</surname><given-names>BY</given-names></name></person-group>. <article-title>Ovarian Cancer</article-title>. <source>Nat Rev Dis Primers</source> (<year>2016</year>) <volume>2</volume>:<fpage>16061</fpage>. <pub-id pub-id-type="doi">10.1038/nrdp.2016.61</pub-id>
<pub-id pub-id-type="pmid">27558151</pub-id>
</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stewart</surname><given-names>C</given-names></name><name><surname>Ralyea</surname><given-names>C</given-names></name><name><surname>Lockwood</surname><given-names>S</given-names></name></person-group>. <article-title>Ovarian Cancer: An Integrated Review</article-title>. <source>Semin Oncol Nurs</source> (<year>2019</year>) <volume>35</volume>(<issue>2</issue>):<fpage>151</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.soncn.2019.02.001</pub-id>
<pub-id pub-id-type="pmid">30867104</pub-id>
</mixed-citation></ref></ref-list></back></article>